The role of genetics in the risk of thromboembolism: prothrombin 20210A and oral contraceptive therapy.

Journal of the American Academy of Nurse Practitioners

Volumn 16, Issue 3, 2004, Pages 106-115

  Welker, Glade C ^a   Lookinland, Sandra ^a   Tiedeman, Mary E ^a   Beckstrand, Renea L ^a  

^a SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; ORAL CONTRACEPTIVE AGENT; PROTHROMBIN;

CHEMICALLY INDUCED DISORDER; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HUMAN; INCIDENCE; MUTATION; PRIMARY HEALTH CARE; REVIEW; RISK FACTOR; STANDARD; THROMBOEMBOLISM; VEIN THROMBOSIS; WOMEN'S HEALTH;

CONTRACEPTIVES, ORAL, HORMONAL; FACTOR V; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MUTATION; POLYMORPHISM, GENETIC; PRIMARY HEALTH CARE; PROTHROMBIN; RISK FACTORS; THROMBOEMBOLISM; VENOUS THROMBOSIS; WOMEN'S HEALTH;

MLCS; MLOWN;

EID: 2542494285     PISSN: 10412972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1745-7599.2004.tb00381.x     Document Type: Review

References (27)